Wellington Management Group LLP Purchases 115,278 Shares of Cencora, Inc. $COR

Wellington Management Group LLP grew its position in Cencora, Inc. (NYSE:COR) by 3.0% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 3,971,121 shares of the company’s stock after purchasing an additional 115,278 shares during the period. Wellington Management Group LLP’s holdings in Cencora were worth $1,241,094,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in COR. IAG Wealth Partners LLC bought a new position in Cencora in the third quarter valued at about $30,000. Cloud Capital Management LLC bought a new stake in Cencora during the 3rd quarter worth about $31,000. Caitlin John LLC bought a new stake in Cencora during the 3rd quarter worth about $31,000. Vermillion & White Wealth Management Group LLC lifted its position in Cencora by 69.4% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock valued at $31,000 after purchasing an additional 43 shares during the period. Finally, Westside Investment Management Inc. lifted its position in Cencora by 200.0% during the 3rd quarter. Westside Investment Management Inc. now owns 105 shares of the company’s stock valued at $33,000 after purchasing an additional 70 shares during the period. Institutional investors and hedge funds own 97.52% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Robert P. Mauch sold 5,096 shares of the company’s stock in a transaction that occurred on Tuesday, January 20th. The stock was sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the sale, the chief executive officer owned 66,726 shares in the company, valued at $23,669,713.98. This represents a 7.10% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Silvana Battaglia sold 1,677 shares of the stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $345.00, for a total value of $578,565.00. Following the completion of the sale, the executive vice president directly owned 18,796 shares of the company’s stock, valued at approximately $6,484,620. The trade was a 8.19% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 15,220 shares of company stock valued at $5,282,867 in the last 90 days. 0.38% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on COR shares. Barclays lifted their price target on shares of Cencora from $400.00 to $425.00 and gave the stock an “overweight” rating in a research report on Friday, February 13th. Wall Street Zen lowered shares of Cencora from a “buy” rating to a “hold” rating in a report on Friday, November 28th. Bank of America lowered their target price on shares of Cencora from $380.00 to $360.00 and set a “neutral” rating for the company in a report on Monday, January 5th. Robert W. Baird set a $415.00 target price on shares of Cencora in a report on Tuesday, January 13th. Finally, JPMorgan Chase & Co. raised their price target on Cencora from $417.00 to $419.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 10th. Eleven equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Cencora has a consensus rating of “Moderate Buy” and a consensus target price of $399.00.

Cencora Stock Down 0.8%

NYSE:COR opened at $349.69 on Friday. The company has a debt-to-equity ratio of 3.62, a quick ratio of 0.51 and a current ratio of 0.92. Cencora, Inc. has a 52-week low of $252.49 and a 52-week high of $377.54. The company has a market cap of $68.03 billion, a PE ratio of 42.03, a PEG ratio of 1.64 and a beta of 0.68. The stock has a 50-day simple moving average of $355.58 and a 200 day simple moving average of $338.13.

Cencora (NYSE:COR) last announced its earnings results on Wednesday, February 4th. The company reported $4.08 EPS for the quarter, topping the consensus estimate of $4.04 by $0.04. The business had revenue of $85.93 billion during the quarter, compared to analysts’ expectations of $86.12 billion. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The firm’s revenue was up 5.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $3.73 earnings per share. On average, sell-side analysts expect that Cencora, Inc. will post 15.37 EPS for the current fiscal year.

Cencora Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Shareholders of record on Friday, February 13th were paid a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Friday, February 13th. Cencora’s dividend payout ratio (DPR) is currently 28.85%.

Cencora Profile

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.